The value of bone marrow biopsy in breast cancer at time of diagnosis. A prospective study

Bone marrow biopsies (BMB) were performed in 173 consecutive unselected breast cancer patients at the time of diagnosis to define the value of this diagnostic tool in the initial staging of mammary carcinoma. In a group of 160 patients with a negative standard staging work‐up, BMB was positive in two (1%). Both of them had negative x‐ray but bone scan was positive in one and doubtful in the other. Bone marrow biopsy was positive in 31% of 13 additional patients with metastatic disease and in 44% of the nine among them with radiologically involved skeleton. These results exclude that BMB is able to discover micrometastatic foci of neoplastic disease. Its positivity appears strictly correlated with that of bone x‐ray and scan. Based on the results of this prospective study, BMB is not required when both bone survey and scan are negative, but could be useful in clarifying diagnostic doubts of skeletal involvement.

[1]  L. Hughes,et al.  FAILURE OF TETRACHLORODECAOXYGEN ANION COMPLEX TO ASSIST WOUND HEALING , 1989, The Lancet.

[2]  L. Faling,et al.  The value of the bone scan and bone marrow biopsy in staging small cell lung cancer , 1985, Cancer.

[3]  T. Powles,et al.  DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCER , 1983, The Lancet.

[4]  C. Redmond,et al.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update , 1983, Cancer.

[5]  M. Marangolo,et al.  Clinical Relevance of Bone Marrow Biopsy in Staging and Follow-Up of Breast Cancer , 1983, Tumori.

[6]  S. Ménard,et al.  Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. , 1983, Cancer research.

[7]  K. Landys,et al.  Prognostic value of bone marrow biopsy in breast cancer , 1982, Cancer.

[8]  B. Ridell,et al.  Incidence and histopathology of metastases of mammary carcinoma in biopsies from the posterior iliac crest , 1979, Cancer.

[9]  J. Ingle,et al.  The bone marrow examination in breast cancer. Diagnostic considerations and clinical usefulness , 1978, Cancer.

[10]  Gurmukh Singh,et al.  Bone marrow examination for metastatic tumor. Aspirate and biopsy , 1977, Cancer.

[11]  G. Bonadonna,et al.  The CMF program for operable breast cancer with positive axillary nodes: Updated analysis on the disease‐free interval, site of relapse and drug tolerance , 1977, Cancer.

[12]  C. Redmond,et al.  L‐phenylalanine mustard (L‐PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L‐PAM plus 5‐fluorouracil (5‐FU) , 1977, Cancer.

[13]  S. Jones,et al.  Non‐Hodgkin's lymphomas. I. Bone marrow involvement , 1972, Cancer.

[14]  R. Silver,et al.  Importance of bone marrow biopsy in the clinical staging of hodgkin's disease , 1970, Cancer.

[15]  R. A. Willis.  The Spread of Tumours in the Human Body , 1934, Nature.

[16]  G. Bonadonna,et al.  Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience. , 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[17]  J. Halama.  [The metastasizing carcinoma in radiotherapeutic view]. , 1966, Der Radiologe.